Skip to main content

Advertisement

SpringerLink
Log in

Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms

  • Pictorial Essay
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Despite advances in molecular biology, imaging, and treatment, gastric neoplasms remain a significant cause of morbidity and mortality; gastric adenocarcinoma is the fifth most common malignancy and third most common cause of death worldwide (Brenner et al., Methods Mol Biol 472:467–477, 2009; Howson et al. Epidemiol Rev 8:1–27, 1986; Roder, Gastric Cancer 5(Suppl 1):5–11, 2002; Ferlay et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, 2013). Because of both the frequency at which malignant gastric tumors occur as well as the worldwide impact, gastric neoplasms remain important lesions to identify and characterize on all imaging modalities. Despite the varied histologies and behaviors of these neoplasms, many have similar imaging features. Nonetheless, the treatment, management, and prognosis of gastric neoplasms vary by pathology, so it is essential for the radiologist to make every effort to differentiate between these lesions and raise the less common entities as differential diagnostic considerations when appropriate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472:467–477. doi:10.1007/978-1-60327-492-0_23

    Article  PubMed  Google Scholar 

  2. Howson CP, Hiyama T, Wynder EL (1986) The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 8:1–27

    Article  CAS  PubMed  Google Scholar 

  3. Roder DM (2002) The epidemiology of gastric cancer. Gastric Cancer 5(Suppl 1):5–11

    Article  PubMed  Google Scholar 

  4. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed on October 28, 2014

  5. Park SH, Han JK, Kim TK, Lee JW, Kim SH, Kim YI, Choi BI, Yeon KM, Han MC (1999) Unusual gastric tumors: radiologic-pathologic correlation. Radiographics 19(6):1435–1446. doi:10.1148/radiographics.19.6.g99no051435

  6. Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. Classification of tumours of the digestive system, 4th edn. IARC Press, Lyon

  7. Hamilton SR, Aaltonen LA (eds) (2000) World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. IARC Press, Lyon

  8. Washington K (2010) 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 17(12):3077–3079. doi:10.1245/s10434-010-1362-z

    Article  PubMed  Google Scholar 

  9. Yoon H, Lee DH (2014) New approaches to gastric cancer staging: beyond endoscopic ultrasound, computed tomography and positron emission tomography. World J Gastroenterol 20(38):13783–13790. doi:10.3748/wjg.v20.i38.13783

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bentley-Hibbert S, Schwartz L (2015) Use of Imaging for GI Cancers. J Clin Oncol 33(16):1729–1736. doi:10.1200/JCO.2014.60.2847

    Article  PubMed  Google Scholar 

  11. Park do Y, Lauwers GY (2008) Gastric polyps: classification and management. Arch Pathol Lab Med 132(4):633–640. doi:10.1043/1543-2165(2008)132[633:GPCAM]2.0.CO;2

  12. Feczko PJ, Halpert RD, Ackerman LV (1985) Gastric polyps: radiological evaluation and clinical significance. Radiology 155(3):581–584. doi:10.1148/radiology.155.3.4001357

    Article  CAS  PubMed  Google Scholar 

  13. Carmack SW, Genta RM, Schuler CM, Saboorian MH (2009) The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 104(6):1524–1532. doi:10.1038/ajg.2009.139

    Article  PubMed  Google Scholar 

  14. Ba-Ssalamah A, Prokop M, Uffmann M, Pokieser P, Teleky B, Lechner G (2003) Dedicated multidetector CT of the stomach: spectrum of diseases. Radiographics 23(3):625–644. doi:10.1148/rg.233025127

  15. Harned RK, Buck JL, Sobin LH (1995) The hamartomatous polyposis syndromes: clinical and radiologic features. AJR Am J Roentgenol 164(3):565–571. doi:10.2214/ajr.164.3.7863873

    Article  CAS  PubMed  Google Scholar 

  16. Levy AD, Quiles AM, Miettinen M, Sobin LH (2005) Gastrointestinal schwannomas: CT features with clinicopathologic correlation. AJR Am J Roentgenol 184(3):797–802. doi:10.2214/ajr.184.3.01840797

    Article  PubMed  Google Scholar 

  17. Kang HC, Menias CO, Gaballah AH, Shroff S, Taggart MW, Garg N, Elsayes KM (2013) Beyond the GIST: mesenchymal tumors of the stomach. Radiographics 33(6):1673–1690. doi:10.1148/rg.336135507

  18. Hong HS, Ha HK, Won HJ, et al. (2008) Gastric schwannomas: radiological features with endoscopic and pathological correlation. Clin Radiol 63(5):536–542. doi:10.1016/j.crad.2007.05.026

    Article  CAS  PubMed  Google Scholar 

  19. Hur BY, Kim SH, Choi JY, et al. (2011) Gastroduodenal glomus tumors: differentiation from other subepithelial lesions based on dynamic contrast-enhanced CT findings. AJR Am J Roentgenol 197(6):1351–1359. doi:10.2214/AJR.10.6360

    Article  PubMed  Google Scholar 

  20. Miettinen M, Paal E, Lasota J, Sobin LH (2002) Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 26(3):301–311

    Article  PubMed  Google Scholar 

  21. Taylor AJ, Stewart ET, Dodds WJ (1990) Gastrointestinal lipomas: a radiologic and pathologic review. AJR Am J Roentgenol 155(6):1205–1210. doi:10.2214/ajr.155.6.2122666

    Article  CAS  PubMed  Google Scholar 

  22. Lee MH, Choi D, Park MJ, Lee MW (2012) Gastric cancer: imaging and staging with MDCT based on the 7th AJCC guidelines. Abdom Imaging 37(4):531–540. doi:10.1007/s00261-011-9780-3

    Article  PubMed  Google Scholar 

  23. Levy AD, Abbott RM, Rohrmann CAJr, Frazier AA, Kende A (2001) Gastrointestinal hemangiomas: imaging findings with pathologic correlation in pediatric and adult patients. AJR Am J Roentgenol 177(5):1073–1081. doi:10.2214/ajr.177.5.1771073

    Article  CAS  PubMed  Google Scholar 

  24. Park SH, Han JK, Choi BI, et al. (2000) Heterotopic pancreas of the stomach: CT findings correlated with pathologic findings in six patients. Abdom Imaging 25(2):119–123

    Article  CAS  PubMed  Google Scholar 

  25. Cho JS, Shin KS, Kwon ST, et al. (2000) Heterotopic pancreas in the stomach: CT findings. Radiology 217(1):139–144. doi:10.1148/radiology.217.1.r00oc09139

    Article  CAS  PubMed  Google Scholar 

  26. Kim JY, Lee JM, Kim KW, et al. (2009) Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma. Radiology 252(1):92–100. doi:10.1148/radiol.2521081441

    Article  PubMed  Google Scholar 

  27. Fishman EK, Urban BA, Hruban RH (1996) CT of the stomach: spectrum of disease. Radiographics 16(5):1035–1054. doi:10.1148/radiographics.16.5.8888389

  28. Motohara T, Semelka RC (2002) MRI in staging of gastric cancer. Abdom Imaging 27(4):376–383. doi:10.1107/s00261-001-0118-4

    Article  CAS  PubMed  Google Scholar 

  29. Binstock AJ, Johnson CD, Stephens DH, Lloyd RV, Fletcher JG (2001) Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol 176(4):947–951. doi:10.2214/ajr.176.4.1760947

    Article  CAS  PubMed  Google Scholar 

  30. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M (1998) CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Modern Pathol 11(8):728–734

  31. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M (2003) Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 23(2):283–304, 456; quiz 532. doi:10.1148/rg.232025146

  32. Burkill GJ, Badran M, Al-Muderis O, et al. (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 226(2):527–532. doi:10.1148/radiol.2262011880

    Article  PubMed  Google Scholar 

  33. Agaimy A, Wunsch PH (2009) Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients < or = 40 years: an overview based on our case material and the literature. Langenbeck’s archives of surgery / Deutsche Gesellschaft fur Chirurgie 394(2):375–381. doi:10.1007/s00423-008-0449-5

    Article  Google Scholar 

  34. Miettinen M, Wang ZF, Sarlomo-Rikala M, et al. (2011) Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 35(11):1712–1721. doi:10.1097/PAS.0b013e3182260752

    Article  PubMed  PubMed Central  Google Scholar 

  35. Doyle LA, Hornick JL (2014) Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase. Histopathology 64(1):53–67. doi:10.1111/his.12302

    Article  PubMed  Google Scholar 

  36. Choi H, Charnsangavej C, de Castro Faria S, et al. (2004) CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183(6):1619–1628. doi:10.2214/ajr.183.6.01831619

    Article  PubMed  Google Scholar 

  37. Holdsworth CH, Badawi RD, Manola JB, et al. (2007) CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR Am J Roentgenol 189(6):W324–330. doi:10.2214/AJR.07.2496

    Article  PubMed  Google Scholar 

  38. Taxy JB, Battifora H (1988) Angiosarcoma of the gastrointestinal tract. A report of three cases. Cancer 62(1):210–216

    Article  CAS  PubMed  Google Scholar 

  39. Restrepo CS, Martinez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P, Koshy P (2006) Imaging manifestations of Kaposi sarcoma. Radiographics 26(4):1169–1185. doi:10.1148/rg.264055129

  40. Ghai S, Pattison J, Ghai S, O’Malley ME, Khalili K, Stephens M (2007) Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics 27(5):1371–1388. doi:10.1148/rg.275065151

  41. Ferrucci PF, Zucca E (2007) Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 136(4):521–538. doi:10.1111/j.1365-2141.2006.06444.x

    Article  CAS  PubMed  Google Scholar 

  42. Campoli PM, Ejima FH, Cardoso DM, et al. (2006) Metastatic cancer to the stomach. Gastric Cancer 9(1):19–25. doi:10.1007/s10120-005-0352-5

    Article  PubMed  Google Scholar 

  43. Mesa H, Rawal A, Rezcallah A, et al. (2009) “Burned out” testicular seminoma presenting as a primary gastric malignancy. Int J Clin Oncol 14(1):74–77. doi:10.1007/s10147-008-0804-0

    Article  PubMed  Google Scholar 

  44. Yamamoto H, Deshmukh N, Gourevitch D, et al. (2007) Upper gastrointestinal hemorrhage as a rare extragonadal presentation of seminoma of testis. Int J Urol 14(3):261–263. doi:10.1111/j.1442-2042.2007.01685.x

    Article  PubMed  Google Scholar 

  45. Coskun M, Agildere AM, Boyvat F, Tarhan C, Niron EA (1998) Primary choriocarcinoma of the stomach and pancreas: CT findings. Eur Radiol 8(8):1425–1428

    Article  CAS  PubMed  Google Scholar 

  46. Guilford P, Hopkins J, Harraway J, et al. (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402–405. doi:10.1038/32918

    Article  CAS  PubMed  Google Scholar 

  47. Rogers WM, Dobo E, Norton JA, et al. (2008) Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol 32(6):799–809. doi:10.1097/PAS.0b013e31815e7f1a

    Article  PubMed  Google Scholar 

  48. National Comprehensive Cancer Network (NCCN) Gastric Cancer (Version 1.2014). 2014

  49. Brosens LA, Langeveld D, van Hattem WA, Giardiello FM, Offerhaus GJ (2011) Juvenile polyposis syndrome. World J Gastroenterol WJG 17(44):4839–4844. doi:10.3748/wjg.v17.i44.4839

    Article  CAS  PubMed  Google Scholar 

  50. van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME (2010) High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 105(6):1258–1264; author reply 1265. doi:10.1038/ajg.2009.725

  51. Capelle LG, Van Grieken NC, Lingsma HF, et al. (2010) Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 138(2):487–492. doi:10.1053/j.gastro.2009.10.051

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Author C.S.F. is supported by GI SPORE Grant # P50CA127003.

Author information

Authors and Affiliations

  1. Department of Radiology, Brigham and Women’s Hospital, 75 Francis St, Boston, MA, 02115, USA

    Danielle M. Richman & Sree Harsha Tirumani

  2. Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, 02115, USA

    Sree Harsha Tirumani, Stephanie Howard, Katherine Krajewski, Nikhil Ramaiya & Michael Rosenthal

  3. Department of Pathology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Jason L. Hornick

  4. Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, MA, 02115, USA

    Charles S. Fuchs

Authors
  1. Danielle M. Richman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sree Harsha Tirumani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason L. Hornick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles S. Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephanie Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Katherine Krajewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nikhil Ramaiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danielle M. Richman.

Ethics declarations

Conflict of Interest

None of the other authors have declared any conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

CME activity This article has been selected as the CME activity for the current month. Please visit https://ce.mayo.edu/node/27947 and follow the instructions to complete this CME activity.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Richman, D.M., Tirumani, S.H., Hornick, J.L. et al. Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms. Abdom Radiol 42, 124–140 (2017). https://doi.org/10.1007/s00261-016-0901-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-016-0901-x

Keywords

Search

Navigation